… played a protective role by alleviating interstitial fibrosis in a mouse model of unilateral ureter
obstruction (2). Human liver stem cells (HLSCs), a stem cell population resident in the liver, …

… In order to investigate whether the up-regulation of β-catenin is a key factor in causing
renal fibrosis, we investigated the expression of β-catenin in mouse kidney cortical fibroblasts (…

… liver transplant. However, the long-term affects of preexisting renal disease on developing
CKD after orthotopic liver … In contrast, in adult liver transplant patients who develop acute renal …

… of HLSC-EVs to interfere with the development of renal fibrosis, we induced 30 min-IRI with
… developed chronic kidney disease that was characterized by worsening renal function and …

… rationale to propose cell therapy and, in particular, MSCs to treat liver fibrosis, overview of …
Some particularities have been documented as in kidney. Indeed, renal fibrosis progression (…

… activities of MSCs have been reported in various fibrotic animal models in the heart, liver,
kidneys, lungs, peritoneum, pancreas, skin, and rectum [54]. MSCs suppress the …

… Fibrosis is a marker of chronic kidney disease (CKD) and consists of the accumulation of the
… deterioration of kidney function. Human liver stem cells (HLSCs) have anti-fibrotic activity, …

… by human liver stem-like cells (HLSCs), on the progression and reversion of … renal fibrosis
that develops during diabetic nephropathy progression was significantly inhibited in stem cell …

… MSC-like cells in myofibroblast-mediated fibrotic disease in the kidney, lung, heart, liver, skin…
Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. …

… signaling pathways) of renal fibrosis, and the effect of stem cell therapy on renal fibrosis as
described in preclinical and clinical studies. We found that stem cells from various sources …